Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Panel

Outstanding Issues 

  • The standard SDTM uses the term study treatment for several variables ( AEREL, AEACN. Should this be changes to study product (or another term).  

This is an example of a CRF used to collect all adverse experiences that occurred after informed consent is obtained. Adverse experiences were collect using free-text.  This CRF was designed to allow the sponsor to use either AEENRF or AEENRTPT to represent an event that was ongoing. This SDTM dataset used MHENRTPT. More information can be found in  SDTMIG Section 4.4.7, Use of Relative Timing Variables

...

This SDTM dataset illustrates data collected on the example AE CRF above,  AEs were coded using MedDRA, and the sponsor’s applicant’s procedures include the possibility of modifying the reported term to aid in coding. The CRF was structured so that seriousness category variables (e.g., AESDTH, AESHOSP) were checked only when AESER is answered “Y.” In this study, the study reference period started at the start of study treatmentproduct exposure. Three AEs were reported for this subject. This SDTM dataset used AEENRF to represent Ongoing events. . More information can be found in  SDTMIG ongoing events. Expected variables (e.g., AELLT, AELLTCD, AEPT, AEPTCD, AEHLT, AEHLTCD, AEHLGT, AEHLCTCD, AEBDSYCD, AESOC, AESOCCD) are not included to save space.  

The applicant also collected information about whether the event was associated with a device. These subjects did not have any device-related issues. See Section 3.3.3.4, Tobacco Product Events and Malfunctions, for an example of device-related eventsSection 4.4.7, Use of Relative Timing Variables.  

Dataset wrap
Rowcaps
Rows 1-2:

Show examples of modifying the reported term for coding purposes, with the modified term in AEMODIFY. These adverse events were not serious, so the seriousness criteria variables are null. Note that for the event in row 2, AESTDY = "1". Day 1 was the day

treatment

product was started; the AE start and end times, as well as dates, were collected to allow comparison of the AE timing to the start of

treatment

product.

Row 3:Shows an example of the overall seriousness question AESER answered with "Y" and the relevant corresponding seriousness category variables (AESHOSP and AESLIFE) answered "Y". The other seriousness category variables are left blank. This row also shows AEENRF being populated because the AE was marked as “Continuing” as of the end of the study reference period for the subject (see Section 4.4.7, Use of Relative Timing Variables).
Dataset2
RowSTUDYIDDOMAINSPDEVIDUSUBJIDAESEQAETERMAEMODIFYAEDECODAEBODSYSAESEVAESERAEACNAEACNDEVAERELAERLDEVAEOUTAESCONGAESDISABAESDTHAESHOSPAESLIFEAESMIEAECONTRTEPOCHAESTDTCAEENDTCAESTDYAEENDYAEENRF
1ABC123AE123101
ABC123-00011POUNDING HEADACHEHEADACHEHeadacheNervous system disordersSEVERENNOT APPLICABLE
DEFINITELY NOT RELATED
RECOVERED/RESOLVEDSCREENING





YPRODUCT EXPOSURE20062005-10-121420052006-10-1218-12-15
2ABC123AE123101
ABC123-00012BACK PAIN FOR 6 HOURSBACK PAINBack painMusculoskeletal and connective tissue disordersMODERATENDOSE REDUCED
PROBABLY RELATED
RECOVERED/RESOLVEDTREATMENT





NPRODUCT EXPOSURE20062005-10-13T13:0520052006-10-13T19:0011
3ABC123AE
ABC123-000212310113INFLUENZAPULMONARY EMBOLISMInfluenzaPulmonary embolismVascular disordersInfluenzaInfections and infestationsSEVEREMODERATEYDOSE REDUCEDPRODUCT WITHDRAWN
PROBABLY NOT RELATED
RECOVERING/RESOLVING


YYTREATMENT2005-10-21
YPRODUCT EXPOSURE2006-02-26
129
AFTER